GATA2 mutation predisposition typically results in cellular immunodeficiency, leading to recurrent infections and autoimmune conditions. For individuals with GATA2-related MDS/AML, notable immune dysfunction often serves as the primary presentation (35). This evidence concerns the gene GATA2 and acute myeloid leukemia.